Status:

COMPLETED

Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children

Lead Sponsor:

Ipsen

Conditions:

Diarrhoea

Eligibility:

MALE

1-36 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the effectiveness of Smecta at decreasing stool weight, when compared to placebo, in the treatment of acute diarrhoea in children.

Eligibility Criteria

Inclusion

  • male
  • acute watery diarrhoea defined as at least 3 watery stools per 24 hours
  • duration of watery diarrhoea of less than 72 hours and with at least one watery stool during the last 12 hours
  • dehydration signs requiring oral rehydration according to current WHO guidelines

Exclusion

  • severe dehydration that needs IV therapy
  • presence of gross blood in stools
  • fever \> 39 degrees Celsius
  • current treatment by an antidiarrheal medication

Key Trial Info

Start Date :

June 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2007

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00352716

Start Date

June 1 2006

End Date

February 1 2007

Last Update

November 22 2019

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Instituto Especializado de Salud del Niño

Breña, Peru

2

Hospital de Vitarte

Cercado, Peru

3

Hospital General de Huacho

Huacho, Peru

4

Hospital Regional de Ica

Ica, Peru